Skip to content
Search

Latest Stories

Mixed views on benefits of cannabis oil products

By Nadeem Badshah

TOP pharmacists are divided on the benefits of cannabis oil products being sold to treat pain.


Around 1.3 million UK consumers spend £300 million a year on CBD goods, research has shown, with a number of specialist stores opening in high streets across the country.

Cannabidiol, or CBD, is a chemical found in the cannabis plant. The products are legal if sold as a food supplement but require medical permission if offered as a medicine.

It has led to a string of CBD medical marijuana card online doctor infused products including oils, muscle balms, anti-ageing creams and sex lubricants. A Hemp and CBD Expo is taking place at the NEC in Birmingham on February 29-March 1.

Pharmacist Nader Siabi has urged people to buy them from chemists to get advice on whether it is dangerous to take with other medicine and to do research on the CBD content of products.

Siabi, from the North East London Pharmaceutical Committee, told Eastern Eye: "Some companies made claims they were not able to substantiate but one produced the lab data and batch numbers.

"There is no scientific claims for the benefits but people who use them say it is working. We put CBD in the pharmacy and from the first week people are buying them.

"We are selling drugs, sprays and balm for joint pains for example. We see people coming for repeat purchases, they have found some benefit.

"Whether it is a placebo effect or it is helping them, I believe in it 100 per cent now due to patient feedback.

"You have to do your due diligence and ensure patients have the necessary information about drug interactions [mixing with other medicine]."

CBD products contain a non-psychoactive chemical found in the hemp plant. It has become trendy among people in the past year over claims it helps with pain and insomnia.

Between 2002 and 2012 there were nine published studies on the use of CBD for the treatment of pain.

By 2017, there had been 30 with most showing potential benefits for pain relief but the studies involved small participant numbers and mostly rats.

Vikesh Patel, who owns four pharmacists in south east England, said he is sceptical about CBD.

He told Eastern Eye: "There is no evidence of the product claims on anxiety, constipation.

"If it's that great why haven't they done a clinical trial?

"If the user is not intellectual and learned enough, they can be fobbed off.

"We are selling CBD oral drops, skin creams and sprays out of business need and we go with companies that have some data and do not sell to under 18s.

"Before it was homeopathic medicines, there was no evidence for it, and they clamped down on it being sold in pharmacies."

Since last October, cannabis-based products can be prescribed by specialist hospital doctors in cases of children with rare, severe forms of epilepsy and adults with vomiting or nausea caused by chemotherapy or muscle stiffness from multiple sclerosis.

A spokesman for the National Pharmacy Association said it would welcome more research and guidance that makes it easier for manufacturers, health care professionals, retailers and consumers to make informed choices.

“Our advice to pharmacists considering whether to stock non-medicinal CBD products is to ensure they are acting legally and putting the needs of patients first – which is the same advice we’d give about all other products sold or supplied in pharmacies.

"In the case of non-medicinal CBD products, pharmacists should take account of current Home Office guidance.

“Currently the evidence about the long term effects of these products is limited and the regulations are complex."

Kings College London (KCL) secured funding to carry out a large-scale trial to test whether CBD could be useful in treating young people at high risk of developing psychosis.

Dr Sagnik Bhattacharyya, from KCL's psychiatry, psychology and neuroscience unit said few of the claims for CBD's effects have been tested but scientists are looking whether large doses could help treat severe mental health problems.

He added: "We have carried out a couple of studies where we show that a single 600mg dose of cannabidiol can normalise brain function in key regions we know are abnormal in people with psychosis."

More For You

Tesco Clubcard Changes: Update Your App Before the Deadline

The digital Clubcard offers convenience and flexibility

Getty

Tesco Clubcard changes: Customers urged to update app before Monday deadline

Tesco has issued an urgent call for action to millions of its Clubcard users, advising them to update their Tesco Shopping & Clubcard app before Monday, 31 March 2025. The supermarket giant is rolling out an important update to improve data protection and online security, and failure to update the app by the deadline will leave customers unable to access their digital Clubcard benefits.

Update to ensure enhanced security

The upcoming changes are being implemented to enhance the security of customer data and improve overall protection. Tesco has highlighted the importance of this upgrade, as it seeks to safeguard customer information and keep their online shopping experiences secure.

Keep ReadingShow less
OpenAI Restricts ChatGPT’s Image Feature After Viral Ghibli Trend

Altman addressed the impact of the popular Ghibli-style image trend on OpenAI’s resources

Getty

OpenAI limits ChatGPT’s image generation feature amid viral Ghibli image trend

OpenAI CEO Sam Altman has announced temporary limitations on the company’s image generation feature in response to overwhelming demand driven by a viral trend. On Thursday, Altman addressed the impact of the popular Ghibli-style image trend on OpenAI’s resources, particularly its reliance on GPUs (graphics processing units). Altman revealed that the surge in demand for ChatGPT’s image generation tool has led to significant strain on the company’s infrastructure, prompting the introduction of temporary speed limits for users.

In a post on X (formerly Twitter), Altman shared the company’s response to the unexpected demand, stating, “It’s super fun seeing people love images in ChatGPT, but our GPUs are melting. We are going to temporarily introduce some rate limits while we work on making it more efficient. Hopefully won’t be long! ChatGPT free tier will get 3 generations per day soon.”

Keep ReadingShow less
UK-business-district-Getty
The Canary Wharf business district including global financial institutions in London. (Photo: Getty Images)

Economic growth in 2024 slightly higher than estimated: ONS

THE UK economy grew slightly more than first estimated in 2024, according to official data released on Friday, providing a small boost for the government after it revised down its growth forecast for 2025.

The Office for National Statistics (ONS) said gross domestic product expanded by 1.1 per cent in 2024, up from an initial estimate of 0.9 per cent.

Keep ReadingShow less
Sri Lanka posts five per cent GDP growth as it ends years of economic decline

Sri Lanka's president Anura Kumara Dissanayake

Sri Lanka posts five per cent GDP growth as it ends years of economic decline

CASH-STRAPPED Sri Lanka’s economy grew by five per cent in 2024, marking the first full year of expansion since its unprecedented meltdown in 2022, official data showed last Tuesday (18).

The last quarter of 2024 saw the economy expand by 5.4 per cent, bringing the full calendar year’s GDP growth to five per cent, compared to a contraction of 2.3 per cent in 2023.

Keep ReadingShow less
Donald Trump

Speaking from the Oval Office, Trump said, 'What we’re going to be doing is a 25 per cent tariff on all cars that are not made in the US.'

Getty Images

Trump imposes 25 per cent tariffs on foreign-built cars

US president Donald Trump has announced a 25 per cent tariff on imported cars and auto parts, escalating trade tensions with key partners.

The new duties take effect on 3 April and apply to foreign-made cars and light trucks, with additional levies on key auto parts set to follow within the month.

Keep ReadingShow less